Powered by

Generation Bio closes $110M series C round

Jan 15, 2020 - SNL Financial
Investments

The round was led by T. Rowe Price funds and accounts.

Generation Bio Co. secured $110 million in series C funding led by T. Rowe Price Group Inc. funds and accounts.

Farallon Capital Management LLC and Wellington Management Co. LLP also participated in the round, alongside existing backers Atlas Venture LP, Fidelity Management & Research Co., The Invus Group LLC, Casdin Capital LLC, Deerfield Management Co. LP, Foresite Capital Management LLC and an entity related to SVB Leerink LLC...